While the prostate naturally relies on lipid metabolism, there is a way to reroute metabolic function and activate glucose uptake, which provides a novel means of FDG and other metabolic prostate imaging, according to a study presented during the American Association for Cancer Research (AACR) annual meeting being held April 5-9 in San Diego, Calif.

Strand Genomics, the genomics software company in Rockville, Md., and San Francisco, Calif., announced April 1 that a selection of technology has been prepared for the company’s Strand Centers for Genomics and Personalized Medicine across the U.S.

A neural stem cell treatment is stepping up in the hopes of one day helping stroke patients regain more neurologic function.

Not only does alcoholism lead to neural atrophy and diminish total brain weight, but it also leads to a dramatic drop in the levels of select proteins in the brain, according to an article published April 3 in PLOS ONE.

Pittsburgh-based pharmaceutical research and development firm Cognition Therapeutics (CogRx) announced April 1 that the company’s patent for numerous drug therapy candidates have been approved.

Hypertension and other cardiovascular risk factors from early adulthood and beyond have a direct impact on future cognitive ability, according to a study published March 31 in Circulation.

The ongoing deposition of beta-amyloid in the aging brain is related to central arterial stiffness, according to a study published online March 31 in JAMA Neurology.

Samsung Electronics America, Inc., a subsidiary of Samsung Electronics Co. Ltd, today announced its first premium ultrasound system – the Samsung UGEO WS80A – designed to redefine ultrasound for women’s health. Combining Samsung’s latest medical imaging innovations and 5D technology, the Samsung UGEO WS80A is among a number of innovative medical imaging products Samsung is showcasing at the American Institute of Ultrasound in Medicine’s (AIUM) Annual Convention at Caesars Palace, Octavius Ballroom, Booth #301.